Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -317,418 | -227,876 | -130,751 | -65,649 | -235,937 |
| Depreciation Amortization | -1,931 | -1,545 | -1,007 | -137 | 571 |
| Accounts payable and accrued liabilities | -8,955 | -7,964 | -21,378 | -28,758 | 22,970 |
| Other Working Capital | -19,491 | -14,406 | -28,585 | -32,828 | 26,307 |
| Other Operating Activity | 55,426 | 43,757 | 48,316 | 48,835 | -2,069 |
| Operating Cash Flow | $-292,369 | $-208,034 | $-133,405 | $-78,537 | $-188,158 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -317,443 | -264,729 | -207,691 | -181,386 | -44,262 |
| PPE Investments | -2,376 | -1,301 | -1,048 | -191 | -729 |
| Purchase Of Investment | 105,180 | 76,215 | 40,076 | 1,740 | 126,473 |
| Sale Of Investment | 10,563 | 1,749 | N/A | N/A | 1,829 |
| Investing Cash Flow | $-204,076 | $-188,066 | $-168,663 | $-179,837 | $83,311 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 809,895 | 806,259 | 788,250 | 408,388 | 54,322 |
| Financing Cash Flow | $809,895 | $806,259 | $788,250 | $408,388 | $54,322 |
| Beginning Cash Position | 123,941 | 123,941 | 123,941 | 123,941 | 174,466 |
| End Cash Position | 437,391 | 534,100 | 610,123 | 273,955 | 123,941 |
| Net Cash Flow | $313,450 | $410,159 | $486,182 | $150,014 | $-50,525 |
| Free Cash Flow | |||||
| Operating Cash Flow | -292,369 | -208,034 | -133,405 | -78,537 | -188,158 |
| Capital Expenditure | -2,376 | -1,301 | -1,048 | -191 | -729 |
| Free Cash Flow | -294,745 | -209,335 | -134,453 | -78,728 | -188,887 |